Clinical Trials in Arizona

Showing 9221-9240 of 16,770 trials

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

NCT02987829

This is a multi-center, first-in-human, open-label, Phase 1/2A dose-escalation study in which eligible patients with metastatic castration-resistant prostate carcinoma (mCRPC) will receive oral doses of TRC253. The study will be conducted in 2 parts: part 1 (dose escalation) and part 2 (dose expansion).

Metastatic Castrate-resistant Prostate CancerAdenocarcinoma, Prostate

Tracon Pharmaceuticals Inc.72 participantsStarted May 2017

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Santa Monica, California, United States +2 more locations

TERMINATEDPhase 331 miles

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

NCT03259308

The purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based on composite score of patient-reported symptoms and centrally read endoscopy, in participants with moderate to severe ulcerative colitis (UC).

Ulcerative Colitis

Shire279 participantsStarted Dec 2017

Mesa, Arizona, United States • Phoenix, Arizona, United States • Anaheim, California, United States +204 more locations

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Find Trials by Condition in Arizona

SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

Age of Blood in Children in Pediatric Intensive Care Units

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Heart Sounds Registry

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Corneal Collagen Cross-Linking for Ectasia (CXL)

Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG

Bio-equivalence Study Between SAPHRIS and Asenapine

Post Approval Study of the remedē System

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event